Catalyst Wire Dossier Catalyst Wire Dossier

CL-108 tablets

· Charleston Laboratories, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CL-108 tablets, covering 2019-10-14 to 2019-10-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route [Phase 1]

See pricing